Technology

A subsidiary of Marlborough medical device firm Hologic has landed the U.S. and Canadian distribution rights of a Pennsylvania medical equipment manufacturer's nitrous oxide and oxygen systems.

Despite just $5.8 million in cash to its name, Holliston organ bioengineering firm Biostage is eyeing a 2019 U.S. Food and Drug Administration application for its esophagus-regenerating device.

A total of 16 Central Massachusetts companies made Inc. 5000's 2018 list of the 5,000 fastest growing companies in the country.

Worcester State University criminal justice majors will be able to get a master's degree in counter-terrorism a year ahead of time under a new agreement with Nichols College in Dudley.

Marlborough medical device company Hologic is suspending the marketing and distribution of a vaginal heating device after the company receiving a warning from the U.S. Food and Drug Administration.

Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement.

Mustang Bio's Worcester facility will play a role in a new exclusive partnership with a leading children's medical center to help develop treatments for an immunodeficiency disorder.

Hopkinton-based Spring Bank Pharmaceuticals wants to raise $37.5 million to fund clinical trials, studies and research and other corporate purposes.

Southborough global IT firm Virtusa is facing a $7.4-million loss in its first quarter despite its revenues jumping 32 percent year-over-year and 6.6 percent sequentially.

Boston Scientific will soon submit the final technical module to the U.S. Food and Drug Administration for a heart valve product.